1. Home
  2. ATRC vs BLND Comparison

ATRC vs BLND Comparison

Compare ATRC & BLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRC
  • BLND
  • Stock Information
  • Founded
  • ATRC 2000
  • BLND 2012
  • Country
  • ATRC United States
  • BLND United States
  • Employees
  • ATRC N/A
  • BLND N/A
  • Industry
  • ATRC Medical/Dental Instruments
  • BLND EDP Services
  • Sector
  • ATRC Health Care
  • BLND Technology
  • Exchange
  • ATRC Nasdaq
  • BLND Nasdaq
  • Market Cap
  • ATRC 1.1B
  • BLND 959.7M
  • IPO Year
  • ATRC 2005
  • BLND 2021
  • Fundamental
  • Price
  • ATRC $38.47
  • BLND $3.61
  • Analyst Decision
  • ATRC Strong Buy
  • BLND Buy
  • Analyst Count
  • ATRC 9
  • BLND 8
  • Target Price
  • ATRC $41.78
  • BLND $4.86
  • AVG Volume (30 Days)
  • ATRC 493.3K
  • BLND 3.7M
  • Earning Date
  • ATRC 02-13-2025
  • BLND 03-13-2025
  • Dividend Yield
  • ATRC N/A
  • BLND N/A
  • EPS Growth
  • ATRC N/A
  • BLND N/A
  • EPS
  • ATRC N/A
  • BLND N/A
  • Revenue
  • ATRC $447,573,000.00
  • BLND $156,715,000.00
  • Revenue This Year
  • ATRC $17.75
  • BLND $5.35
  • Revenue Next Year
  • ATRC $13.44
  • BLND $20.75
  • P/E Ratio
  • ATRC N/A
  • BLND N/A
  • Revenue Growth
  • ATRC 17.56
  • BLND N/A
  • 52 Week Low
  • ATRC $18.94
  • BLND $2.08
  • 52 Week High
  • ATRC $39.05
  • BLND $5.53
  • Technical
  • Relative Strength Index (RSI)
  • ATRC 70.10
  • BLND 35.81
  • Support Level
  • ATRC $31.00
  • BLND $3.23
  • Resistance Level
  • ATRC $34.11
  • BLND $3.75
  • Average True Range (ATR)
  • ATRC 1.76
  • BLND 0.23
  • MACD
  • ATRC 0.86
  • BLND -0.03
  • Stochastic Oscillator
  • ATRC 93.03
  • BLND 32.33

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.

About BLND Blend Labs Inc.

Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segments are; Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience, and the Title segment enables customers to streamline the title, settlement, and closing process at scale for mortgages, home equity lines of credit, and home equity loans. The majority of the revenue for the company is generated from the Blend Platform segment.

Share on Social Networks: